000			03544nam a2200205 4500
001			00008644
005			20230312181425.0
008			071224s20032003cl d g 001 0 engsd
040			_aDO-SdBDB _bspa _cDO-SdBDB
041			_aeng
043			_acl
050			_aHD 47 .4 _b.M35 2003
245			_aMaking choices in health : _bwho guide to cost-effectiveness analysis / _cedited by Tessa Tan-Torres Edejer, Rob Baltussen, Taghreed Adam, Raymond Hutubessy, Arnab. Acharya, David B. Evans and Christopher J.L. Murray.
260			_aGeneva : _bWorld Health Organization, _c2003.
300			_axxii, 318 páginas : _bilustradas con gráficos ; _c23 cm.
505	0	0	_aPreface, ix -- _tList of acronyms and abbreviations, xxi -- _tPart one. Methods for generalized cost-effectiveness analysis -- _t1. What is generalized cost-effectiveness analysis?, 3 -- _t2. Undertaking a study using GCEA, 17 -- _t3. Estimating costs, 29 -- _t4. Estimating health effects, 49 -- _t5. Discounting, 67 -- _t6. Uncertainty in cost-effectiveness analysis, 73 -- _t7. Policy uses of Generalized CEA, 83 -- _t8. Reporting CEA results, 91 -- _t9. Summary of recommendations, 93 -- _tReferences, 97 -- _tAnnex A. Who-choice activities on generalized cost-effectiveness analysis, 107 -- _tAnnex B. Draft list of intervention clusters for evaluation / _rby Who-Choice, 110 -- _tAnnex C. An illustration of the types of costs included in a selection of intervention activities at central levels, 111 -- _tAnnex D. Interpreting international dollars, 112 -- _tAnnex E. Dalys to measure burden of disease, 113 -- _tAnnex F. Measuring intervention benefit at the population level, 115 -- _tAnnex G. Epidemiological subregions as applied in WHO generalized CEA, 118 -- _tEndnotes, 119 -- _tPart two. Background papers and applications -- _t1. Development of who guidelines on generalized cost-effectiveness analysis / _rChristopher J.L. Murray, David B. Evans, Arnab Acharya, Rob M.P.M. Baltussen, 125 -- _t2. PopMod: A longitudinal population model with two interacting disease states / _rJeremy A. Lauer, Klaus Rohrich, Harold Wirth, Claude Charette, Steve Gribble, Christopher J.L. Murray, 151 -- _t3. Programme costs in the economic evaluation of health interventions / _rBenjamin Johns, Rob Baltussen, Raymond Hutubessy, 177 -- _t4. Econometric estimation of country-specific hospital costs / _rTaghreed Adam, David B. Evans, Christopher J.L. Murray, 197 -- _t5. Stochastic league tables: communicating cost-effectiveness results to decision-makers / _rRaymond C. W. Hutubessy, Rob M.P.M. Baltussen, David B. Evans, Jan J. Barendregt, Christopher J.L. Murray, 217 -- _t6. Uncertainty in cost-effectiveness analysis: probabilistic uncertainty analysis and stochastic league tables / _rRob M.P.M. Baltussen, Raymond C. W. Hutubessy, David B. Evans, Christopher J.L. Murray, 225 7. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk / _rChristopher J.L. Murray, Jeremy A. Lauer, Raymond C. W. Hutubessy, Louis Niessen, Niels Tomijima, Anthony Rodgers, Carlene M.M. Lawes, David B. Evans, 237 -- _t8. Generalized cost-effectiveness analysis: an aid to decision making in health / _rRaymond C. W. Hutubessy, Rob M.P.M. Baltussen, Tessa Tan-Torres Edejer, David B. Evans, 277 -- _t9. Ethical issues in the use of cost effectiveness analysis for the prioritization of health care resources / _rDan W. Brock, 289 -- _tIndex, 313.
650			_aAnálisis costo-beneficio.
650			_aSalud.
942			_cCG
999			_c58602 _d58602